ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
ResMed (NYSE: RMD, ASX: RMD) announces it will release its fourth quarter fiscal year 2024 earnings on August 1, 2024, after the NYSE closes. Management will host a webcast to discuss the financial and operational results. Investors and stakeholders will gain insights into the company's performance and future outlook.
- Scheduled announcement of Q4 FY 2024 earnings indicates transparency.
- Management webcast provides additional insights into company’s performance.
- None.
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2024 on Thursday, August 1, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| http://investor.resmed.com | |
| Thursday, August 1, 2024 | |
| 1:30 p.m. PDT / 4:30 p.m. EDT | |
| London, Thursday, August 1, 2024, 9:30 p.m. BST Sydney, Friday, August 2, 2024, 6:30 a.m. AEST |
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 1, 2024, until August 15, 2024, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13747201
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed release its Q4 FY 2024 earnings?
What is the significance of ResMed's earnings release on August 1, 2024?
Will ResMed management discuss the Q4 FY 2024 results?
